CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Preferred stock, Beginning balance (in shares) at Dec. 31, 2021		0
Common stock, Beginning balance (in shares) at Dec. 31, 2021			155,137,237
Beginning balance at Dec. 31, 2021	$ 168,767	$ 0	$ 16	$ 320,937	$ (391)	$ (151,795)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,340			5,340
Issuance of common stock upon exercise of stock options (in shares)			656,303
Issuance of common stock upon exercise of stock options	222			222
Issuance of common stock upon vesting of restricted stock units (in shares)			856,917
Taxes related to net share settlement of equity awards (in shares)			(285,533)
Taxes related to net share settlement of equity awards	(1,149)			(1,149)
Change in net unrealized loss on available-for-sale securities, net of tax	(1,056)				(1,056)
Net loss	(24,881)					(24,881)
Preferred stock, Ending balance (in shares) at Mar. 31, 2022		0
Common stock, Ending balance (in shares) at Mar. 31, 2022			156,364,924
Ending balance at Mar. 31, 2022	147,243	$ 0	$ 16	325,350	(1,447)	(176,676)
Preferred stock, Beginning balance (in shares) at Dec. 31, 2021		0
Common stock, Beginning balance (in shares) at Dec. 31, 2021			155,137,237
Beginning balance at Dec. 31, 2021	168,767	$ 0	$ 16	320,937	(391)	(151,795)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in net unrealized loss on available-for-sale securities, net of tax	(1,238)
Net loss	(51,348)
Preferred stock, Ending balance (in shares) at Jun. 30, 2022		0
Common stock, Ending balance (in shares) at Jun. 30, 2022			158,475,630
Ending balance at Jun. 30, 2022	127,588	$ 0	$ 16	332,344	(1,629)	(203,143)
Preferred stock, Beginning balance (in shares) at Mar. 31, 2022		0
Common stock, Beginning balance (in shares) at Mar. 31, 2022			156,364,924
Beginning balance at Mar. 31, 2022	147,243	$ 0	$ 16	325,350	(1,447)	(176,676)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	6,557			6,557
Issuance of common stock upon exercise of stock options (in shares)			1,105,298
Issuance of common stock upon exercise of stock options	446			446
Issuance of common stock upon vesting of restricted stock units (in shares)			883,318
Taxes related to net share settlement of equity awards (in shares)			(312,920)
Taxes related to net share settlement of equity awards	(1,431)			(1,431)
Issuance of common stock under Common Stock Purchase Agreement (in shares)			435,000
Issuance of common stock under the Common Stock Purchase Agreement	1,422			1,422
Issuance of stock upon exercise of public warrants			10
Change in net unrealized loss on available-for-sale securities, net of tax	(182)				(182)
Net loss	(26,467)					(26,467)
Preferred stock, Ending balance (in shares) at Jun. 30, 2022		0
Common stock, Ending balance (in shares) at Jun. 30, 2022			158,475,630
Ending balance at Jun. 30, 2022	$ 127,588	$ 0	$ 16	332,344	(1,629)	(203,143)
Preferred stock, Beginning balance (in shares) at Dec. 31, 2022	0	0
Common stock, Beginning balance (in shares) at Dec. 31, 2022	163,099,124		163,099,124
Beginning balance at Dec. 31, 2022	$ 93,970	$ 0	$ 16	345,742	(1,279)	(250,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	6,513			6,513
Issuance of common stock upon exercise of stock options (in shares)			2,069,081
Issuance of common stock upon exercise of stock options	391			391
Issuance of common stock upon vesting of restricted stock units (in shares)			2,983,790
Taxes related to net share settlement of equity awards (in shares)			(1,320,828)
Taxes related to net share settlement of equity awards	(867)			(867)
Conversion of convertible note into common stock (in shares)			4,138,414
Conversion of convertible note into common stock	1,755		$ 1	1,754
Other comprehensive income, net of tax	469				469
Net loss	(26,265)					(26,265)
Preferred stock, Ending balance (in shares) at Mar. 31, 2023		0
Common stock, Ending balance (in shares) at Mar. 31, 2023			170,969,581
Ending balance at Mar. 31, 2023	$ 75,966	$ 0	$ 17	353,533	(810)	(276,774)
Preferred stock, Beginning balance (in shares) at Dec. 31, 2022	0	0
Common stock, Beginning balance (in shares) at Dec. 31, 2022	163,099,124		163,099,124
Beginning balance at Dec. 31, 2022	$ 93,970	$ 0	$ 16	345,742	(1,279)	(250,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in net unrealized loss on available-for-sale securities, net of tax	910
Net loss	$ (42,296)
Preferred stock, Ending balance (in shares) at Jun. 30, 2023	0	0
Common stock, Ending balance (in shares) at Jun. 30, 2023	181,420,313		181,420,313
Ending balance at Jun. 30, 2023	$ 65,656	$ 0	$ 18	358,833	(390)	(292,805)
Preferred stock, Beginning balance (in shares) at Mar. 31, 2023		0
Common stock, Beginning balance (in shares) at Mar. 31, 2023			170,969,581
Beginning balance at Mar. 31, 2023	75,966	$ 0	$ 17	353,533	(810)	(276,774)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	4,110			4,110
Issuance of common stock upon vesting of restricted stock units (in shares)			2,562,467
Taxes related to net share settlement of equity awards (in shares)			(895,829)
Taxes related to net share settlement of equity awards	(181)			(181)
Conversion of convertible note into common stock (in shares)			8,119,992
Conversion of convertible note into common stock	1,254		$ 1	1,253
Issuance of common stock through Employee Stock Purchase Plan (in shares)			664,102
Issuance of common stock through Employee Stock Purchase Plan	118			118
Other comprehensive income, net of tax	420				420
Change in net unrealized loss on available-for-sale securities, net of tax	420
Net loss	$ (16,031)					(16,031)
Preferred stock, Ending balance (in shares) at Jun. 30, 2023	0	0
Common stock, Ending balance (in shares) at Jun. 30, 2023	181,420,313		181,420,313
Ending balance at Jun. 30, 2023	$ 65,656	$ 0	$ 18	$ 358,833	$ (390)	$ (292,805)